Publication

Article

Applied Clinical Trials

Applied Clinical Trials-04-01-2025
Volume34
Issue 2

Applied Clinical Trials: April 2025 Interactive Digital Edition

View the Applied Clinical Trials April 2025 issue in an interactive format.

Click here to view our interactive April 2025 issue!

Download Issue PDF
Articles in this issue
Applied Clinical Trials: April 2025 Interactive Digital Edition
Applied Clinical Trials: April 2025 Interactive Digital Edition
What’s Next for DEI?
What’s Next for DEI?
The Impact of DEI Ban On Clinical Research Ecosystem
The Impact of DEI Ban On Clinical Research Ecosystem
Tapping the Patient Voice as a Strategic Differentiator
Tapping the Patient Voice as a Strategic Differentiator
Benchmarking Risks Across Therapeutic Areas
Benchmarking Risks Across Therapeutic Areas
Scaling eSource-Enabled Clinical Trials: Hospital Perspectives
Scaling eSource-Enabled Clinical Trials: Hospital Perspectives

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Navigating Complexity: Strategies to Accelerate Modern Clinical Trials
August 6th 2025

Navigating Complexity: Strategies to Accelerate Modern Clinical Trials

Cindy Henderson
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 6th 2025

ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials

Applied Clinical Trials Editorial Staff
Credit: Lisa | stock.adobe.com
August 6th 2025

FDA Grants Priority Review to Breyanzi for Relapsed Marginal Zone Lymphoma

Andy Studna, Senior Editor
Unifying Industry to Better Understand GCP Guidance
August 6th 2025

Unifying Industry to Better Understand GCP Guidance

Andy Studna, Senior Editor
FDA Clears Anbogen’s Oral HDAC1/2/3 Inhibitor for Phase I/II Colorectal Trial
August 6th 2025

FDA Clears Anbogen’s Oral HDAC1/2/3 Inhibitor for Phase I/II Colorectal Trial

Don Tracy, Associate Editor
© photon_photo - © photon_photo - stock.adobe.com
August 6th 2025

Clinical Trial Failure Isn’t an Inevitable Risk—It’s Insurable and Opening the Door to New Investors

Scott Foster Natalie Marquess, ARM, CIC, CRM
© 2025 MJH Life Sciences

All rights reserved.